PARK-seq logo

Database for molecular studies in neurodegenerative research

Database statistics What is PARK-seq? Citation

Database statistics

37 papers

  • 1 to 23 files per paper, with a mean average of 8 files per paper.
  • 6 to 189 figures or tables per paper, with a mean average of 45 figures or tables per paper.
  • 20 to 65,487 data points per paper, with a mean average of 14,791 data points per paper.

78,999 unique gene lookup values

  • 1 to 192 entries per gene, with a mean average of 6 entries per gene.
  • 1 to 16 studies per gene, with a mean average of 2.5 studies per gene.

15 categories

  • 23 disease-control
  • 11 cell type
  • 10 cell marker
  • 5 disease
  • 4 control
  • 4 mechanistic
  • 4 neuropathology
  • 4 reference
  • 2 control-control
  • 2 disease-disease
  • 1 brain region
  • 1 development
  • 1 experimental condition
  • 1 female-male
  • 1 subject information

values are number of studies with


15 regions, tissues, or models

  • 7 prefrontal cortex
  • 5 frontal cortex
  • 4 blood
  • 4 entorhinal cortex
  • 4 iPSCs
  • 4 substantia nigra
  • 3 brain white matter
  • 3 midbrain
  • 3 temporal cortex
  • 2 genetics
  • 1 caudate nucleus
  • 1 embryo ventral midbrain
  • 1 globus pallidus
  • 1 putamen
  • 1 striatum
  • 1 urine

values are number of studies with

What is PARK-seq?

PARK-seq provides a unifying database for molecular studies on neurodegenerative disease in humans. Part of the detail-oriented approach that makes PARK-seq unique includes:

  • Standardization of names
    • Gene, non-coding products, and protein symbols are standardized across over a decade of studies through meticulous database cross-referencing and dogged searches.
  • Clear formatting
    • Increases and decreases are immediately evident and standardized across studies (ex. Disease vs control, more severe pathology vs less severe)
  • Cohort and study details
    • Key details of each study are embedded in the table allowing for comparison of disparate results within the framework of cohort: age, disease, biological sex, geographical region, and neuropathology; as well as, experiment: substrate extraction and purification, sequencing technology, post-processing, and statistical analysis.
    • Additionally, detailed notes are provided covering errors, confusing text, and missing data.
  • Detailed filtering tools
    • The database can be searched for any string, or filtered using buttons that cover every item included in the table.
  • Manual curation
    • A molecular neuroscientist hand-curates all information, increasing accuracy and allowing for meticulous cross-referencing to derive as much information as possible on cohort demographics. This approach is also used for the gene standardization, allowing for recording of disparities where found.

Citation

  • PARK-seq [Internet]. Phoenix (AZ, USA). 2026 March 23 [updated 2026 May 25; cited {YEAR} {MONTH} {DAY}]. Available from: https://parkseq.com.

  • Kelley CM, Manfredsson FP. PARK-seq [Internet]. Phoenix (AZ, USA): CMK Data and Barrow Neurological Institute. 2026 March 1 [updated 2026 May 25; cited {YEAR} {MONTH} {DAY}]. Available from: https://parkseq.com.